Search

everythinglearnresearchcommunity

for

Search:↓

Some chemotherapy can cause permanent hair loss.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

RANK-RANKL signaling is essential for hair growth and skin health.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Improving the environment and cell interactions is key for creating human hair in the lab.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Avoiding certain nutrients and drugs may help manage pemphigus.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Hormonal therapies are safe and effective for treating adult women's acne.